American Association for Cancer Research
Browse
- No file added yet -

Supplementary Table S1 from How to Provide the Needed Protection from COVID-19 to Patients with Hematologic Malignancies

Download (61.99 kB)
journal contribution
posted on 2023-04-04, 01:06 authored by Antoni Ribas, Madhav V. Dhodapkar, Katie M. Campbell, Faith E. Davies, Steven D. Gore, Ronald Levy, Lee M. Greenberger

Supplementary Table S1

Funding

NCI

Parker Institute for Cancer Immunotherapy

Ressler Family Fund

Leukemia and Lymphoma Society

History

ARTICLE ABSTRACT

Patients with hematologic malignancies are particularly vulnerable to COVID-19 infections, and upon a pooled data analysis of 24 publications, there is evidence that they have suboptimal antibody responses to COVID-19 vaccination and boosters. To provide them the needed additional protection from COVID-19, it is imperative to achieve a 100% full immunization rate in health care workers and adult caretakers, and to foster research to test higher doses and repeated rounds of COVID-19 vaccines and the use of passive immune prophylaxis and therapy.

Usage metrics

    Blood Cancer Discovery

    Categories

    Keywords

    Hematological Cancers

    Licence

    CC BY

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC